116 related articles for article (PubMed ID: 26548547)
1. Molecular rationale delineating the role of lycopene as a potent HMG-CoA reductase inhibitor: in vitro and in silico study.
Alvi SS; Iqbal D; Ahmad S; Khan MS
Nat Prod Res; 2016 Sep; 30(18):2111-4. PubMed ID: 26548547
[TBL] [Abstract][Full Text] [Related]
2. Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait.
Iqbal D; Khan MS; Khan MS; Ahmad S; Hussain MS; Ali M
Lipids Health Dis; 2015 Mar; 14():15. PubMed ID: 25884722
[TBL] [Abstract][Full Text] [Related]
3. In-silico HMG-CoA reductase-inhibitory and in-vivo anti-lipidaemic/anticancer effects of carotenoids from Spondias mombin.
Metibemu DS; Akinloye OA; Akamo AJ; Okoye JO; Omotuyi IO
J Pharm Pharmacol; 2021 Sep; 73(10):1377-1386. PubMed ID: 34343336
[TBL] [Abstract][Full Text] [Related]
4. An in vitro and molecular informatics study to evaluate the antioxidative and β-hydroxy-β-methylglutaryl-CoA reductase inhibitory property of Ficus virens Ait.
Iqbal D; Khan MS; Khan MS; Ahmad S; Srivastava AK
Phytother Res; 2014 Jun; 28(6):899-908. PubMed ID: 24151056
[TBL] [Abstract][Full Text] [Related]
5. The effect of pravastatin on hepatic 3-hydroxy-3-methylglutaryl CoA reductase obtained from poloxamer 407-induced hyperlipidemic rats.
Johnston TP; Palmer WK
Pharmacotherapy; 1997; 17(2):342-7. PubMed ID: 9085326
[TBL] [Abstract][Full Text] [Related]
6. Optimization of Ultrasonic-Assisted Extraction of Total Phenolics from
Hao K; Hu W; Hou M; Cao D; Wang Y; Guan Q; Zhang X; Wang A; Yu J; Guo B
Molecules; 2019 Jun; 24(13):. PubMed ID: 31248058
[TBL] [Abstract][Full Text] [Related]
7. An in vitro study of the hydroxyl radical scavenging property of fluvastatin, and HMG-CoA reductase inhibitor.
Suzumura K; Yasuhara M; Tanaka K; Odawara A; Narita H; Suzuki T
Chem Pharm Bull (Tokyo); 1999 Jul; 47(7):1010-2. PubMed ID: 10434403
[TBL] [Abstract][Full Text] [Related]
8. Investigation of HMG-CoA reductase inhibitory and antioxidant effects of various hydroxycoumarin derivatives.
Ozalp L; Danış Ö; Yuce-Dursun B; Demir S; Gündüz C; Ogan A
Arch Pharm (Weinheim); 2020 Oct; 353(10):e1900378. PubMed ID: 32648617
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity by ascorbic acid. An effect mediated by the free radical monodehydroascorbate.
Harwood HJ; Greene YJ; Stacpoole PW
J Biol Chem; 1986 Jun; 261(16):7127-35. PubMed ID: 3711081
[TBL] [Abstract][Full Text] [Related]
10. Potential Effect of Baobab's Polyphenols as Antihyperlipidemic Agents: In Silico Study.
Alameen AA; Alothman MR; Al Wahibi MS; Abdullah EM; Ali R; Abdalla M; Fattiny SZA; Elsayim R
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630364
[No Abstract] [Full Text] [Related]
11. Statins: 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors demonstrate anti-atherosclerotic character due to their antioxidant capacity.
Puttananjaiah MK; Dhale MA; Gaonkar V; Keni S
Appl Biochem Biotechnol; 2011 Jan; 163(2):215-22. PubMed ID: 20640529
[TBL] [Abstract][Full Text] [Related]
12.
Fajriaty I; Fidrianny I; Kurniati NF; Fauzi NM; Mustafa SH; Adnyana IK
Saudi J Biol Sci; 2024 May; 31(5):103964. PubMed ID: 38500815
[TBL] [Abstract][Full Text] [Related]
13. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
[TBL] [Abstract][Full Text] [Related]
14. Antioxidative and Inhibitory Effects of the Fruiting Body of Black Lingzhi Mushroom, Amauroderma rugosum (Agaricomycetes), on LDL Oxidation and HMG-CoA Reductase Activity.
Seng CK; Abdullah N; Aminudin N
Int J Med Mushrooms; 2017; 19(9):797-807. PubMed ID: 29199554
[TBL] [Abstract][Full Text] [Related]
15. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
[TBL] [Abstract][Full Text] [Related]
17. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.
Palozza P; Colangelo M; Simone R; Catalano A; Boninsegna A; Lanza P; Monego G; Ranelletti FO
Carcinogenesis; 2010 Oct; 31(10):1813-21. PubMed ID: 20699249
[TBL] [Abstract][Full Text] [Related]
18. The in vitro inhibitory effect of tannin derivatives on 3-hydroxy-3-methylglutaryl-coenzyme a reductase on vero cells.
Chang JJ; Chen TH; Chan P; Chen YJ; Hsu FL; Lo MY; Lin JY
Pharmacology; 2001 May; 62(4):224-8. PubMed ID: 11359999
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in silico studies of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitory activity of the cowpea Gln-Asp-Phe peptide.
Silva MBCE; Souza CADC; Philadelpho BO; Cunha MMND; Batista FPR; Silva JRD; Druzian JI; Castilho MS; Cilli EM; Ferreira ES
Food Chem; 2018 Sep; 259():270-277. PubMed ID: 29680054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
